XERS- Xeris Biopharma Holdings, Inc.

Insider activity in XERS over the last quarter tilts toward selling: insiders offloaded a net 16,667 shares worth roughly $101K.

XERS sits in the Biotechnology industry within the Health Care sector, so this activity is best read against the sector's broader insider trend.

Insider Ownership

Role	Insider	Shares	Value	30d
Other	Shannon John Patrick Jr	3.16M	$26.50M	-
Other	McCulloch Kevin	1.79M	$14.98M	-
Other	Pieper Steven	1.46M	$12.26M	-
Other	Hecht Beth	1.18M	$9.87M	-
Dir	Johnson John	698.1K	$5.86M	-

Buys and sells only

10 filings

Date	Insider	Role	Type	Shares	Price	Value	Chg%	3M	12M
Jun 1, 2026	Hecht Beth46	See Remarks	Sell	16,667	$6.06	$100,982.02	-1.4%	-	-
May 1, 2026	Hecht Beth46	See Remarks	Sell	16,667	$6.23	$103,805.41	-1.4%	+34.1%	-
Feb 2, 2026	Hecht Beth46	See Remarks	Sell	16,667	$7.45	$124,147.48	-1.3%	-14.7%	-
Jan 8, 2026	McCulloch Kevin	See Remarks	Sell	15,000	$8.00	$120,000.00	-0.9%	-27.2%	-
Jan 5, 2026	Shannon John Patrick Jr53	See Remarks	Sale+OE	24,907	$7.08	$176,256.88	-0.9%	-14.7%	-
Jan 2, 2026	Hecht Beth46	See Remarks	Sell	16,667	$7.43	$123,775.81	-1.3%	-17.8%	-
Dec 19, 2025	Johnson John	Director	Sell	135,400	$7.22	$977,019.32	-16.2%	-24.0%	-
Dec 12, 2025	Bormann-Kennedy Barbara-Jean Anne	Director	Sell	15,000	$7.09	$106,414.50	-9.5%	-23.6%	-
Dec 1, 2025	Hecht Beth46	See Remarks	Sell	16,667	$7.01	$116,780.67	-1.2%	-13.5%	-
Nov 13, 2025	Shannon John Patrick Jr53	See Remarks	Sale+OE	23,242	$7.46	$173,401.59	-0.9%	-4.8%	-